A polymeric delivery vehicle, with neutral degradation products, keeps inflammation at bay during sustained drug release following myocardial infarction.
References
Sy, J. C. et al. Nature Mater. 7, 863–869 (2008).
Luman, N. R., Smeds, K. A. & Grinstaff, M. W. Chem. Eur. J. 9, 5618–5626 (2003).
Richards Grayson, A. C. et al. Nature Mater. 2, 767–772 (2003).
Tabata, Y., Gutta, S. & Langer, R. Pharm. Res. 10, 487–496 (1993).
Wang, C. et al. Nature Mater. 3, 190–196 (2004).
Zelikin, A. N., Zawaneh, P. N. & Putnam, D. Biomacromolecules 7, 3239–3244 (2006).
Zawaneh, P. N., Doody, A. M., Zelikin, A. N. & Putnam, D. Biomacromolecules 7, 3245–3251 (2006).
Heffernan, M. J. & Murthy, N. Bioconjug. Chem. 16, 1340–1342 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Putnam, D. The heart of the matter. Nature Mater 7, 836–837 (2008). https://doi.org/10.1038/nmat2309
Issue Date:
DOI: https://doi.org/10.1038/nmat2309
- Springer Nature Limited
This article is cited by
-
Effects of L-lactic acid and D,L-lactic acid on viability and osteogenic differentiation of mesenchymal stem cells
Chinese Science Bulletin (2013)